Composition of Gut Microbiota in Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Background: Autism spectrum disorder (ASD) is a public health problem and has a prevalence of 0.6%–1.7% in children. As well as psychiatric symptoms, dysbiosis and gastrointestinal comorbidities are also frequently reported. The gut–brain microbiota axis suggests that there is a form of communication between microbiota and the brain underlying some neurological disabilities. The aim of this study is to describe and compare the composition of gut microbiota in children with and without ASD. Methods: Electronic databases were searched as far as February 2020. Meta-analyses were performed using RevMan5.3 to estimate the overall relative abundance of gut bacteria belonging to 8 phyla and 17 genera in children with ASD and controls. Results: We included 18 studies assessing a total of 493 ASD children and 404 controls. The microbiota was mainly composed of the phyla Bacteroidetes, Firmicutes, and Actinobacteria, all of which were more abundant in the ASD children than in the controls. Children with ASD showed a significantly higher abundance of the genera Bacteroides, Parabacteroides, Clostridium, Faecalibacterium, and Phascolarctobacterium and a lower percentage of Coprococcus and Bifidobacterium. Discussion: This meta-analysis suggests that there is a dysbiosis in ASD children which may influence the development and severity of ASD symptomatology. Further studies are required in order to obtain stronger evidence of the effectiveness of pre- or probiotics in reducing autistic behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Iglesias-Vázquez et al. [240], based on 18 trials which were overlapping in ca.72% with the trials included in the meta-analysis of Andreo-Martínez [239] showed a reduced quantity of Bacteroidetes, Firmicutes, and Proteobacteria phyla with elevated levels of Bacteroides and Clostridium in guts of ASD people.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [240]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“when the data analyzed by Iglesias-Vázquez et al. were recalculated using the method by Andreo-Martinez, the two analyses gave similar outcome, indicating a lack of the ASD-gut microbiota association in relation to Bacteroidetes, Firmicutes, Proteobacteria, Bacteroides, and Clostridium”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [240]
In the citing paper
“The alterations in the gut microbiota composition in patients with ASD were reported in many studies but when taking into account the results of the recent two meta-analyses, the highest interest should be given only to Bifidobacterium and Streptococcus genera [239,240].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Heterogeneity was assessed by calculating I2 [29].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“The quality of the present meta-analysis was also assessed, using the PRISMA guide [28].”
Methodvon Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Therefore alterations in the gut microbiota could trigger not only some of the GI symptoms that autistic children suffer from but also some of their neuropsychiatric symptoms [13,14].”
BackgroundLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Global Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636
Research works printed but not linked: 1
- Alibek K. Farmer S. Tskhay A. Moldakozhayev A. Alibek K. Isakov T. The Role of Infection, Inflammation and Genetic Alterations in ASD Etiopathogenesis: A Review J. Neurol. Psychiatr Disord. 2019 2 105
Cited by
Items 101–200 of 384
Jendraszak, M., Gałęcka, M., Kotwicka, M., Regdos, A., Pazgrat-Patan, M., & Andrusiewicz, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03794-8 · Cited by 28
Ou, Y., Belzer, C., Smidt, H., & de Weerth, C. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02205-9 · Cited by 26
“Furthermore, recent meta-analytic research described reduced Faecalibacterium in multiple mental disorders [62, 64], such as MDD, bipolar disorder, and ASD, despite a conflicting ASD result reported by another meta-analytic study [65].”
McMath, A. L., Aguilar‐López, M., Cannavale, C. N., Khan, N. A., & Donovan, S. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1171970 · Cited by 29
“While reviews focused on children with neurodevelopmental disabilities report differences in gut microbiome composition (Bundgaard-Nielsen et al., 2020; Iglesias-Vázquez et al., 2020), many studies included are crosssectional or observational, making it difficult to determine whether other symptomology (i.”
BackgroundThe Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review
Diotaiuti, P., Misiti, F., Marotta, G., Falese, L., Calabrò, G. E., & Mancone, S. (2025) · Nutrients · doi:10.3390/nu17213350 · Cited by 27
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Petrella, C., Vecchioli, S. F., Cisale, G. Y., Strimpakos, G., Borg, J.-J., Ceccanti, M., Fiore, M., Monteleone, G., & Nisticò, R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200730111528 · Cited by 27
“A recent large systematic review and meta-analysis compared the composition of gut microbiota in children with and without ASD [162].”
BackgroundChanges to the Gut Microbiome in Young Children Showing Early Behavioral Signs of Autism
Jones, J. C., Reinke, S. N., Mousavi‐Derazmahalleh, M., Palmer, D. J., & Christophersen, C. T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.905901 · Cited by 27
“The bacteriomes from all children in this study were dominated by Firmicutes (62%), Bacteroidota (25%), Actinobacteriota (10%), and the mycobiome was dominated by Saccharomyces (92”
BackgroundResultInfluentialPrevalencia de síntomas gastrointestinales en trastornos del espectro del autismo: un metaanálisis
Lasheras, I., Real‐López, M., & Santabárbara, J. (2023) · Anales de Pediatría · doi:10.1016/j.anpedi.2023.05.011 · Cited by 26
“…en el futuro, recomendamos el uso de cuestionarios validados para el diagnóstico de trastornos GI funcionales en esta población, concretamente, los criterios ROMA IV, herra-mienta aceptada para el diagnóstico y la cuantificación de síntomas GI funcionales por las principales sociedades de Pediatría”
Romano, K., Shah, A., Schumacher, A., Zasowski, C., Zhang, T., Bradley-Ridout, G., Merriman, K., Parkinson, J., Szatmári, P., Campisi, S. C., et al. (2023) · Gut Microbiome · doi:10.1017/gmb.2023.16 · Cited by 27
“, 2021), ASD (Iglesias-Vazquez et al., 2020), ADHD (Ligezka et al.”
BackgroundThe Effect of Gut Microbiome, Neurotransmitters, and Digital Insights in Autism
Bamicha, V., Pergantis, P., & Drigas, A. S. (2024) · Applied Microbiology · doi:10.3390/applmicrobiol4040114 · Cited by 26
Марсова, М. В., Odorskaya, M. V., Novichkova, M., Polyakova, V. S., Abilev, S. K., Kalinina, E. V., Shtil, A. A., Poluektova, E., & Даниленко, В. Н. (2020) · Microorganisms · doi:10.3390/microorganisms8060876 · Cited by 24
Perturbations in gut microbiota in autism spectrum disorder: a systematic review
Tao, X., Li, Z., Wang, D., Pu, J., Liu, Y., Gui, S., Zhong, X., Yang, D., Zhou, H., Tao, W., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1448478 · Cited by 23
“Therefore, the disturbances of butyric acid-producing bacteria may contribute to intestinal inflammation (Iglesias-Vázquez et al., 2020).”
Darmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 25
Zhou, M., Niu, B., Ma, J., Ge, Y., Han, Y., Wu, W., & Yue, C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1535455 · Cited by 36
Kadiyska, T., Vassilev, D. I., Tourtourikov, I., Ciurinskiene, S., Madzharova, D., Savcheva, M., Stoynev, N., Mileva-Popova, R., Tafradjiiska-Hadjiolova, R. K., & Mitev, V. (2025) · Nutrients · doi:10.3390/nu17111775 · Cited by 25
“Bacteroides are also major producers of propionic acid, which in high concentrations “alters gut homeostasis, triggers peripheral inflammation” and can reach the brain via the BBB, where it affects serotonin and dopamine production [34].”
Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions
Manosso, L. M., Lin, J. H. X., Carlessi, A. S., Recco, K. C. C., Quevedo, J., Gonçalves, C. L., & Réus, G. Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.001 · Cited by 24
Tonkaz, G. Y., ESİN, İ. S., Turan, B., Uslu, H., & Dursun, O. B. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05540-z · Cited by 27
“In the literature, there are studies reporting this ratio to be lower (Williams, Hornig, Buie, Bauman, Paik, et al., 2011), while there are also studies that report it to be higher (Finegold et al., 2010; Iglesias-Vázquez et al., 2020).”
BackgroundResultInfluentialZhanfeng, N., Wu, L., Kang, J., Bai, J., Chen, Y., & Hechun, X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.934822 · Cited by 24
“The following five species belong to Proteobacteria, Fusobacteria, Verrucomicrobia, and Cyanobacteria (Finegold et al., 2010; Adams et al., 2011; Iglesias-Vázquez et al., 2020).”
BackgroundWan, Y., Zhang, L., Xu, Z., Su, Q., Leung, T.-F., Chan, D., Wong, O. W. H., Chan, S. S. M., Chan, F. K. L., Tun, H. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101409 · Cited by 31
“29 In contrast to TD children, the relationships between VLSs and Bacteroides were dominated by negative correlations (87.2%), and the relationships between VLSs and Ruminococcus were dominated by positive correlations (87.1”
ResultInfluentialSteckler, R., Magzal, F., Kokot, M., Walkowiak, J., & Tamir, S. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100829 · Cited by 29
“This finding contrasts with the reduced levels of Lachnoclostridium , a genus within the Lachnospiraceae family, as reported by Jiang et al. While the literature presents inconsistent results regarding ADHD and its association with specific bacterial families and genera, it is worth mentioning that Lachnoclostridium h…”
BackgroundInfluentialSales-Millán, A. D., Reyes-Ferreira, P., Garrido, J. F. A., Guillé, I. C., Barrientos-Ríos, R., & Velázquez-Aragón, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126701 · Cited by 24
Congenitally underdeveloped intestine drives autism-related gut microbiota and behavior
Li, J., Wang, H., Wei, Q., Liu, F., Zeng, N., Wu, F., Shi, Y., Gao, X., Cheng, M., Li, H., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.006 · Cited by 22
Ephraim, E., Brockman, J. A., & Jewell, D. E. (2022) · Biology · doi:10.3390/biology11070976 · Cited by 28
“In addition, Blautia was of lower relative abundance in the gut microbiota of children with ASD compared with controls in a systematic review [80] and meta-analysis [81].”
BackgroundResultHorecka-Lewitowicz, A., Lewitowicz, W., Kozieł, D., Lim, H., Lewitowicz, P., & Lewitowicz, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011283 · Cited by 25
Kirby, T. O., Ochoa‐Repáraz, J., Roullet, J., & Gibson, K. M. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.12.289 · Cited by 22
Kim, J. I., Kim, B.-N., Lee, Y. A., Shin, C. H., Hong, Y., & Lim, Y. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114047 · Cited by 20
Dubourdieu, P. M., & Guerendiain, M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1202948 · Cited by 23
Jyonouchi, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1333717 · Cited by 22
A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
Delpire, E. J., & Ben‐Ari, Y. (2022) · Cells · doi:10.3390/cells11152419 · Cited by 21
Role of gut-microbiota in disease severity and clinical outcomes
Yadav, M., & Chauhan, N. S. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac037 · Cited by 21
Gao, Q., Li, D. M., Wang, Y., Zhao, C., Li, M., Xiao, J., Kang, Y., Lin, H., & Wang, N. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02645-y · Cited by 21
“In autism spectrum disorder, Phascolarctobacterium are increased in abundance and their metabolites may contribute to the occurrence and severity of the disorder [36].”
BackgroundChen, X., Zheng, Y., Liu, L., Zhang, R., Zhang, X., Peng, C., Geng, Y., Zhou, F., Han, Y., & Hou, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.912968 · Cited by 21
“Many studies have shown that probiotics are effective against anxiety, depression, autism spectrum disorder (ASD), and obsessive-compulsive disorder, and can also improve cognitive function, learning, and memory ability (Wang et al., 2016; Eastwood et al., 2021; Kim et al., 2021; Alemohammad et al., 2022).”
BackgroundInfluentialMiot, S., Chancel, R., Périés, M., Crepiat, S., Couderc, S., Pernon, É., Picot, M., Gonnier, V., Jeandel, C., Blain, H., et al. (2022) · Autism · doi:10.1177/13623613221121623 · Cited by 19
“These findings, obtained in ASD + ID adults, are consistent with the gut–brain axis and immune dysfunction hypotheses for the pathophysiology of ASD (Iglesias-Vazquez et al., 2020; Ye et al., 2021) and potentially ASD + ID.”
BackgroundResultPatel, M., Atluri, L. M., Gonzalez, N. A., Sakhamuri, N., Athiyaman, S., Randhi, B., Gutlapalli, S. D., Pu, J., Zaidi, M. F., & Khan, S. (2022) · Cureus · doi:10.7759/cureus.32313 · Cited by 23
“Other beneficial bacteria such as Prevotella and Bacteroides increased, while harmful bacteria such as Firmicutes and Clostridium decreased, which aligned with the outcomes of a previous meta-analysis [26].”
ResultVitamin B12 and Autism Spectrum Disorder: A Review of Current Evidence
Zwierz, M., Suprunowicz, M., Mrozek, K., Pietruszkiewicz, J., Oracz, A. J., Konarzewska, B., & Waszkiewicz, N. (2025) · Nutrients · doi:10.3390/nu17071220 · Cited by 21
“Meta-analysis showed that children with ASD exhibit dysbiosis compared to neurotypical children, with specific bacterial groups examined [64].”
Skillington, O., Mills, S., Gupta, A., Mayer, E. A., Gill, C. I. R., Rio, D. D., O’Riordan, K. J., Cryan, J. F., Ross, R. P., & Stanton, C. (2021) · Nutrition and Healthy Aging · doi:10.3233/nha-210129 · Cited by 18
Yang, X., Li, J., Zhou, Y., Zhang, N., & Liu, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1009502 · Cited by 19
“However, due to the influence of the dietary structure and habits of ASD children, considerable heterogeneity is observed in the changes in the intestinal flora (Liu et al., 2019; Iglesias-Vázquez et al., 2020; Zou et al., 2020).”
BackgroundTopic modeling for multi-omic integration in the human gut microbiome and implications for Autism
Tataru, C. A., Peras, M., Rutherford, E. M., Dunlap, K., Yin, X., Chrisman, B., DeSantis, T. Z., Wall, D. P., Iwai, S., & David, M. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-38228-0 · Cited by 17
Yang, J., He, L., Dai, S. Y., Zheng, H., Cui, X., Ou, J., & Zhang, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1294057 · Cited by 17
Gupta, S., Dinesh, S., & Sharma, S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249271548231115071021 · Cited by 20
Yano, N., & Hosokawa, K. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1119142 · Cited by 16
Mohamed, D. I., Nahas, H. H. A., Elshaer, A. M., El-Waseef, D. A. E.-D. A., El-Kharashi, O. A., Mohamed, S. M. Y., Sabry, Y. G., Almaimani, R. A., Almasmoum, H. A., Altamimi, A. S. A., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1268126 · Cited by 19
Autism Spectrum Disorder, Oral Implications, and Oral Microbiota
D’Angelo, E., Fiori, F., Ferraro, G. A., Tessitore, A., Nazzaro, L., Serpico, R., & Contaldo, M. (2025) · Children · doi:10.3390/children12030368 · Cited by 20
Gut microbiota and autism spectrum disorders: where do we stand?
Zyoud, S. H., Shakhshir, M. H., Abushanab, A. S., Koni, A. A., Shahwan, M. J., Jairoun, A. A., Taha, A. A., & Al‐Jabi, S. W. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00575-8 · Cited by 17
“Recent scientific interest has been directed toward exploring the potential contribution of gut microbiota composition as a cofactor in ASD development, given the established bidirectional communication between the gut and the brain, known as the “gut-brain axis” [3, 15].”
BackgroundMethodMancini, V. O., Brook, J., Hernandez, C., Strickland, D. H., Christophersen, C. T., D’Vaz, N., Silva, D. T., Prescott, S. L., Callaghan, B. L., Downs, J. A., et al. (2023) · Developmental Psychobiology · doi:10.1002/dev.22360 · Cited by 19
“…of certain gut microbiota among people with neurodevelopmental and mental health problems, such as autism, anxiety, and schizophrenia (Ho et al., 2020, Iglesias-Vázquez et al., 2020, Xu et al., 2019, Wang et al., 2011, Malan-Muller et al., 2018, Szeligowski et al., 2020, Nguyen et al., 2019).”
BackgroundStructural and functional alteration of the gut microbiota in elderly patients with hyperlipidemia
Meng, X., Xu, Y., Li, H., Huang, J., Zhou, H., Gao, C., & Han, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1333145 · Cited by 18
Morin, C., Faure, F., Mollet, J., Guenoun, D., Olya, A. H., Sautet, I., Diao, S., Faivre, V., Pansiot, J., Tabet, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.023 · Cited by 15
Wang, D., Pang, X., Zhang, H., Gao, H., Leng, Y.-F., Chen, F.-Q., Zhang, R., Feng, Y., & Sun, Z. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052021 · Cited by 16
The effect of microbiome composition on impulsive and violent behavior: A systematic review
Langmajerová, M., Roubalová, R., Šebela, A., & Vevera, J. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114266 · Cited by 16
Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice
Lu, K., Zhou, Y., He, L., Li, Y., Shahzad, M., & Li, D. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae125 · Cited by 15
Mamun, A. A., Geng, P., Wang, S., Shao, C., & Xiao, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107559 · Cited by 16
Genus-Level Analysis of Gut Microbiota in Children with Autism Spectrum Disorder: A Mini Review
Levkova, M., Chervenkov, T., & Pancheva, R. (2023) · Children · doi:10.3390/children10071103 · Cited by 21
“This was in agreement with a published meta-analysis on the subject of the gut microbiome of autistic children [25].”
BackgroundResultInfluentialClinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders
Carreira, L. D., Matias, F. C., & Campos, M. G. (2022) · Biomedicines · doi:10.3390/biomedicines10040796 · Cited by 17
“In addition to the central symptoms of ASDs, there is a varied prevalence, 9–90%, of gastrointestinal problems, which is much higher than that reported in neurotypical patients and also a higher severity and frequency [45] (pp.”
BackgroundMethodSaxami, G., Mitsou, E. K., Kerezoudi, E. N., Mavrouli, I., Vlassopoulou, M., Koutrotsios, G., Mountzouris, K. C., Zervakis, G. I., & Kyriacou, A. (2023) · Microorganisms · doi:10.3390/microorganisms11020414 · Cited by 15
“Although alterations in GM in ASD patients are not always consistent across studies, ASD patients often exhibit microbial imbalances of several types, most notably a higher abundance of the genera Bacteroides, Parabacteroides, Clostridium, Faecalibacterium, and Phascolarctobacterium, and a lower relative abundance of…”
Unraveling the relative abundance of psychobiotic bacteria in children with Autism Spectrum Disorder
Darwesh, M.-A. K., Bakr, W., Omar, T. E. I., El‐Kholy, M. A., & Azzam, N. F. A. E. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-72962-3 · Cited by 18
Lu, H., Nguyen, N. T. K., Panwar, R., Lin, C., Cross, T.-W., & Lin, S. (2025) · Autism Research · doi:10.1002/aur.70091 · Cited by 14
“Although the Firmicutes/Bacteroidetes (F/B) ratio differs between patients with ASD and healthy individuals (de Angelis et al. 2015; Iglesias-Vázquez et al. 2020), no significant correlation has been found between the F/B ratio and GISs or core ASD symptoms (Ahmed et al. 2020).”
Buitrago, M. V., Oliveira-Carvalho, R. D., Cardoso, V. N., Triviño-Valencia, J., Duque, L. M. S., Martínez-Díaz, V., Zabaleta, J., Galeano-Vanegas, N. F., & Galvis, C. A. N. (2025) · Pharmaceuticals · doi:10.3390/ph18091376 · Cited by 16
“These compositional shifts align with global reports linking ASD to dysbiosis and impaired SCFA biosynthesis pathways [58,59], which are critical for gut barrier integrity and immune regulation.”
Pan, J., Chui, L., Liu, T., Zheng, Q., Liu, X., Liu, L., Zhao, Y., Zhang, L., Song, M., Han, J., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03540-22 · Cited by 13
“energy and fat metabolism has rarely been reported, a decreased abundance of Coprococcus has been observed in patients with Parkinson’s disease (40) and autism spectrum disorder (41).”
BackgroundYu, R., Ahmed, T., Jiang, H., Zhou, G., Zhang, M., Lv, L., & Li, B. (2021) · Materials · doi:10.3390/ma14195488 · Cited by 14
“[37] reported that ASD children exhibited a significantly higher abundance of the genera Clostridium, Parabacteroides, Phascolarctobacterium, Faecalibacterium, Bacteroides and a lower percentage of Bifidobacterium and Coprococcus.”
BackgroundOverall Rebalancing of Gut Microbiota Is Key to Autism Intervention
Lu, C. F., Rong, J., Fu, C., Wang, W., Xu, J. B., & Ju, X. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.862719 · Cited by 17
Qian, S., Bao, Y., Li, X., Dong, Y., Zhang, X., & Wu, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04271-9 · Cited by 16
“A higher abundance of Bacteroides , Faecalibacte-rium , and Parabacteroides was found in children with autism spectrum disorder (ASD) than in controls [25].”
Neutrophils in the Focus: Impact on Neuroimmune Dynamics and the Gut–Brain Axis
Kršek, A., & Batičić, L. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6030039 · Cited by 14
“In the context of surgery, changes in the gut microbiota composition post-operation can influence the recurrence rate and disease-free survival of cancer patients [512,513].”
BackgroundGulati, P., Solanki, P. R., Verma, A. K., & Kumar, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309057 · Cited by 12
Neuroglia and the microbiota-gut-brain axis
Blair, H., Morales, L., Cryan, J. F., & Aburto, M. R. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19104-6.00001-2 · Cited by 12
Piazzesi, A., & Putignani, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.958346 · Cited by 14
Wang, H., Bi, H. C., Yang, M., Wang, X., Song, C., Yang, W., Wang, Y., Xie, D., Li, H., & Zhou, Z. (2023) · Hematology · doi:10.1080/16078454.2023.2277501 · Cited by 12
“Elevated Phascolarctobacterium has also been found in other diseases [33, 34].”
BackgroundChen, Y., Xue, Y., Jia, L., Yang, M., Huang, G., & Xie, J. (2024) · Medicine · doi:10.1097/md.0000000000037284 · Cited by 14
“According to the clinical findings, inflammation and immune system dysfunction, which can be mediated by microbiota composition, are key elements in the development of GI problems and other extra-intestinal diseases such as ASD [64] (Fig.”
Nirmalkar, K., Patel, J., Kang, D., Bellinghiere, A., Bowes, D. A., Qureshi, F. A., Adams, J. B., & Krajmalnik‐Brown, R. (2024) · Gut Microbes Reports · doi:10.1080/29933935.2024.2358324 · Cited by 17
Plaza‐Díaz, J., Radar, A. M., Baig, A. T., Leyba, M. F., Costabel, M. M., Zavala-Crichton, J. P., Sanchez‐Martinez, J., MacKenzie, A., & Solis‐Urra, P. (2022) · Children · doi:10.3390/children9121834 · Cited by 14
“Indeed, the gut microbiome has been identified as a critical component in the pathogenesis of ASD in systematic reviews [115] with evidence of dysbiosis which may contribute to the development and severity of symptomatology [116].”
BackgroundZhukova, M., Talantseva, O. I., Logvinenko, T. I., Titova, O. S., & Grigorenko, E. L. (2020) · Clinical Psychology and Special Education · doi:10.17759/cpse.2020090310 · Cited by 12
Plasma cytokine concentrations of children with autism spectrum disorder and neurotypical siblings
Belica, I., Janšáková, K., Celušáková, H., Kopčíková, M., Polónyiová, K., Rašková, B., Vidošovičová, M., Ostatníková, D., & Babinská, K. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156333 · Cited by 12
Machine learning approaches for neurological disease prediction: A systematic review
Fatima, A., & Masood, S. (2024) · Expert Systems · doi:10.1111/exsy.13569 · Cited by 13
“…Boertien, Murtomäki, et al., 2022b; Boertien, Pereira, et al., 2022; Hashish & Salama, 2023; Heinzel et al., 2021; Weis et al., 2021) and ASD (Iglesias-Vázquez et al., 2020; Jendraszak et al., 2021; Jones et al., 2022; Wong et al., 2022; Zuffa et al., 2023) have been published over the past…”
Lombardi, M., & Troisi, J. (2021) · Nutrients · doi:10.3390/nu13103492 · Cited by 13
“Their abundance strongly correlates with the fecal levels of propionic acid (PPA), since they are among the main producers of this metabolite [22,45].”
BackgroundAssociation Between Non-Suicidal Self-Injury and Gut Microbial Characteristics in Chinese Adolescent
Cai, L.-F., Wang, S., Hou, C., Li, Z., Liao, Y.-J., & Jia, F. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s360588 · Cited by 13
Probiotics in autism spectrum disorder: Recent insights from animal models
Golbaghi, N., Naeimi, S., Darvishi, A., Najari, N., & Cussotto, S. (2024) · Autism · doi:10.1177/13623613241246911 · Cited by 12
“In parallel with this, there are less dominant phyla such as Fusobacteria and Verrucomicrobia (Fattorusso et al., 2019) the abundance of which is not influenced by ASD (Iglesias-Vázquez et al., 2020).”
Barba-Vila, O., García‐Mieres, H., & Ramos, B. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae010 · Cited by 14
Gut microbiota and its metabolism in autism spectrum disorder: from pathogenesis to therapy
Bu, W., Chen, Z., Liu, B., & Jia, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1687691 · Cited by 12
Hoffman, K. L., & Cano-Ramírez, H. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2074396 · Cited by 12
Çolak, H., Sarıyer, E. T., & Noğay, N. H. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10254 · Cited by 10
Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
Shin, C., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_2 · Cited by 11
Preterm Birth by Cesarean Section: The Gut-Brain Axis, a Key Regulator of Brain Development
Morin, C., Bokobza, C., Fleiss, B., Hill‐Yardin, E. L., Steenwinckel, J. V., & Gressèns, P. (2023) · Developmental Neuroscience · doi:10.1159/000534124 · Cited by 11
“Speci fi cally, children with ASD had a higher abundance of Bacteroides , Para-bacteroides , Clostridium , Faecalibacterium , whereas Phascolarctobacterium , Coprococcus, and Bi fi dobacterium were observed at lower abundance in neurotypical controls [43].”
BackgroundIntestinal flora and linear growth in children
He, P., Shen, X., & Guo, S. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1252035 · Cited by 11
“Bacteroides , Parabacteroides , Clostridium , Faecalibacterium , and Phascolarctobacterium are more abundant in the gut of ASD children (63).”
BackgroundInfluentialJin, Y., Fan, H., Shi, R., Song, G., Wu, X., Wang, D., Xia, B., Zhao, Z., Zhao, B., Liu, X., et al. (2024) · Food & Function · doi:10.1039/d3fo05078e · Cited by 10
A screening test proposal for congenital defects based on maternal serum metabolomics profile
Troisi, J., Lombardi, M., Scala, G., Cavallo, P., Tayler, R. S., Symes, S. J. K., Richards, S. M., Adair, D. C., Fasano, A., McCowan, L. M. E., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.08.050 · Cited by 11
The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease
Romano-Keeler, J., Zhang, J., & Sun, J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.10.008 · Cited by 10
Bermudez-Martin, P., Becker, J. A. J., Caramello, N., Fernandez, S. P., Campos, R. C., Canaguier, J., Barbosa, S., Martinez-Gili, L., Myridakis, A., Dumas, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.18.101147 · Cited by 10
Gut microbiota as a potential therapeutic target for children with cerebral palsy and epilepsy
Wu, H., Huang, C., & Xiong, S. (2024) · Brain and Development · doi:10.1016/j.braindev.2024.09.002 · Cited by 9
The Contribution of the Gut-Brain-Microbiota Axis to Brain Health Throughout the Lifespan
Qansuwa, E. M., Atalah, H. N., Abdelkader, M. S., Russell, A. E., Dakhlallah, D. A., & Brown, C. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_2 · Cited by 6
Mallaret, G., Canaguier, J., Callebert, J., Caramello, N., Fabregat‐Safont, D., Glaichenhaus, N., Pozo, Ó. J., Launay, J., & Davidovic, L. (2025) · Communications Biology · doi:10.1038/s42003-025-09207-0 · Cited by 11
Wang, Y., & Zhang, Y. (2025) · Neuropharmacology and Therapy · doi:10.15212/npt-2025-0008 · Cited by 10
“These findings are consistent with those from a systematic review indicating that SCFAs-producing bacteria, such as Propionibacterium and Clostridium , are typically diminished in children with ASD [142].”
Exercise Changes Gut Microbiota: A New Idea to Explain that Exercise Improves Autism
Xue, Y., An, S., Qiu, W., Zhang, W., Li-min, F., & Zhen, Z. (2023) · International Journal of Sports Medicine · doi:10.1055/a-2018-2477 · Cited by 10
Wei, J., Chen, J., Fang, X., Liu, T., Yuan, Y., & Zhang, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1236904 · Cited by 9
Seeing beyond words: Visualizing autism spectrum disorder biomarker insights
Xie, X., Zhou, R., Fang, Z., Zhang, Y., Wang, Q., & Liu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30420 · Cited by 9
Ahmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 13
“Verrucomicrobia, Cyanobacteria, Fuso-bacteria, and Tenericutes had relative abundances that were much lower or even down to zero in ASD patients when compared to the controls (Iglesias-Vázquez et al. 2020; Ye et al. 2021) (Supplementary Table 1–5).”
Saposnik, F., & Huber, J. F. (2020) · JMIR Pediatrics and Parenting · doi:10.2196/20913 · Cited by 11
“Some preliminary investigations have suggested that there may be an imbalance of gut bacteria in some children with ASD [44].”
BackgroundProbiotics: current regulatory aspects of probiotics for use in different disease conditions
Pogačar, M. Š., Mičetić‐Turk, D., & Fijan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00021-0 · Cited by 10
Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?: a systematic review
Navarro-Sánchez, A., Nieto-Vitoria, M. Á., López-López, J. A., Martínez-Crespo, J. J., & Navarro‐Mateu, F. (2025) · BMC Cancer · doi:10.1186/s12885-025-13770-4 · Cited by 8
Šoltýsová, M., Tomova, A., Paulinyova, M., Lakatošová, S., Trebatická, J., & Ostatníková, D. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.020 · Cited by 9
de Oliveira, L. I. G., Clementino, J. R., Salgaço, M. K., de Oliveira, S. P. A., Lima, M. D. S., Mesa, V., de Souza, E. L., Vinderola, C. G., Magnani, M., & Sivieri, K. (2023) · Food & Function · doi:10.1039/d3fo01156a · Cited by 9
Agrawal, S., Rath, C. P., Rao, S. C., Whitehouse, A., & Patole, S. (2025) · Microorganisms · doi:10.3390/microorganisms13030545 · Cited by 9
“It is postulated that such dysbiosis may explain the behavioral and gastrointestinal symptoms in ASD, mediated via the immune and inflammatory pathways through the gut–brain axis [58].”
Nova, R. J., Morales, G. I., & Ahumada, D. (2022) · Revista chilena de nutrición · doi:10.4067/s0717-75182022000700753 · Cited by 10
Metadata
- Authors
- Iglesias-Vázquez, L., Van Ginkel Riba, G., Arija, V., & Canals, J.
- Affiliations
- Department of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, 43201 Reus, Spain
- Department of Psychology, Faculty of Education Sciences and Psychology, Universitat Rovira i Virgili, 43007 Tarragona, Spain
- Universitat Rovira i Virgili (ES)
- Corresponding author
- Canals, Josefa
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-03-17
- Volume
- 12
- Issue
- 3
- Pages
- 792
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7146354
- OpenAlex
- W3012535104
- Cited by
- 352
- References
- 73
- Citations by year
- 2026: 52 · 2025: 62 · 2024: 60 · 2023: 66 · 2022: 52 · 2021: 41 · 2020: 18
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Rovira & Virgili repository (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- autism spectrum disorder, gut microbiota, dysbiosis, gut-brain axis, children, Bacteroidetes, Firmicutes, actinobacteria, Bacteroides, Parabacteroides, Clostridium, Faecalibacterium, Phascolarctobacterium, Coprococcus, Bifidobacterium, gastrointestinal comorbidities, probiotics
- MeSH terms
- Autism Spectrum Disorder, Gastrointestinal Microbiome, Bacteria, Child, Female, Humans, Male, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.